Filing Details
- Accession Number:
- 0001179110-15-012556
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-24 18:28:14
- Reporting Period:
- 2015-08-24
- Filing Date:
- 2015-08-24
- Accepted Time:
- 2015-08-24 18:28:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1578845 | Allergan Plc | AGN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1237253 | Paul Bisaro | Clonshaugh Business And Technology Park, Coolock, Co. Dublin L2 D17 E400 | Exec Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares, Par Value $0.0001 | Acquisiton | 2015-08-24 | 1,000 | $297.42 | 421,755 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $297.3228 to $297.46, inclusive. The reporting person undertakes to provide Allergan plc, any security holder of Allergan plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price range set forth in footnote (1) of this Form 4.
- Includes restricted share units issued pursuant to the 2013 Incentive Award Plan of Allergan plc.